How Analytics Can Help Payers Monitor Specialty Drug Costs

With the continued frustration over rising healthcare costs, the White House has made prescription drug reform a top priority. Thomas Beaton of HealthPayerIntelligence recently published an article which shares that payers are eager to see this effort succeed as they also search for ways to best address the high prices of certain medications. In 2016, the U.S. spent $450 billion on prescription drugs, with specialty drugs accounting for 1/3 or about $150 billion of U.S. drug spending. These numbers are staggering especially when you consider that only 2 percent of prescriptions in the U.S. are considered specialty. How can payers control these rising drug costs and take matters into their own hands? To start, they need to identify high-cost members and the prescribed medications to find opportunities for savings.

Gain a bigger view: Specialty drug therapies are managed across various benefit structures and can include different routes of administration. As a result, it’s important to look at claims processed under both medical and pharmacy benefits to understand when and where specialty pharmacy drugs are being obtained and at what cost.

Target high-risk members: Top conditions treated by specialty drugs include multiple sclerosis, rheumatoid arthritis, growth hormone deficiency, hepatitis C, cancer, hemophilia, and immune disorders. Analytics can help bring together disparate data sources to better identify the conditions most impacted by these drugs and opportunities to refine benefit structures, improve adherence and optimize care management programs – all of which can help decrease costs while improving outcomes.

Solutions like MedeAnalytics Healthcare Economics and Population Heath effectively links medical, pharmacy and other data sources to give payers a deeper understanding of specialty pharmacy utilization and costs.

St. Joseph Hospital, part of Covenant Health, was looking to cut overall costs within their employee health plan and found that more than half of their pharma spend came from specialty drugs. To better manage their overall pharmacy spend including both traditional and specialty drugs, they turned to MedeAnalytics.

With MedeAnalytics Population Health, St. Joseph Hospital gained insight into costs and could pinpoint patterns and correlations that revealed opportunities for drug savings, leading them to understand which areas of their pharmaceutical spend needed the most attention. By analyzing the organization’s pharmaceutical data, St. Joseph Hospital achieved their goal of reducing overall pharmaceutical costs. Interested in learning how analytics can help your health plan alleviate rising drug prices? Visit our Population Health solutions page, read the St. Joseph Hospital case study or contact us here.

MedeAnalytics

MedeAnalytics is a leader in healthcare analytics, providing innovative solutions that enable measurable impact for healthcare payers and providers. With the most advanced data orchestration in healthcare, payers and providers count on us to deliver actionable insights that improve financial, operational, and clinical outcomes. To date, we’ve helped uncover millions of dollars in savings annually.

Leave a Comment





Get our take on industry trends

Adapting nursing education and practice in a post-pandemic, technology-dependent world

July 19, 2024

Can AI help reduce nurse burnout? What role should nurses play in regulatory conversations? How do clinical training programs incorporate…

Read on...

Championing transparent technology: Why we’ll always show you behind the scenes

June 19, 2024

Modern, tech-enabled innovations are demonstrating immense potential to transform the way healthcare is planned, delivered and paid for in the…

Read on...

Optimize your revenue cycle for today’s challenges and tomorrow’s goals

May 15, 2024

In this dynamic LinkedIn Live discussion, Christine Stetler, BSN, RN and AVP of Solution Engineering at MedeAnalytics, unearthed strategies for…

Read on...

Enhancing healthcare delivery with explainable AI: A methodological leap forward

April 25, 2024

Healthcare providers and payers continually seek methods to enhance patient care and operational efficiency. With the advent of complex data…

Read on...